Japan is quietly becoming one of Asia’s most promising frontiers for digital therapeutics (DTx). Recent data from U.S. trade analysts confirm that Japan’s market for software-driven, evidence-based medical interventions is gaining policy, clinical, and commercial momentum.<\/p>
2025\u5e744\u6708\u73fe\u5728\u3001\u65e5\u672c\u3067\u627f\u8a8d\u3055\u308c\u3066\u3044\u308bDTx\u306f\u308f\u305a\u304b5\u88fd\u54c1\u3002\u3057\u304b\u3057\u3001\u305d\u306e\u3046\u3061\u56fd\u6c11\u5065\u5eb7\u4fdd\u967a\u304c\u9069\u7528\u3055\u308c\u308b\u306e\u306f2\u88fd\u54c1\u306e\u307f\u3067\u3059\u3002<\/p>
Even with this starting point, projections show strong growth. Sales to healthcare providers are expected to reach about US$ 230 million (¥35 billion) by 2030. This is up from just a few billion yen today.<\/p>
Another forecast from IQVIA indicates the market could expand 8 to 10× by 2030, if regulatory reforms, reimbursement pathways, and clinician awareness advance in tandem.<\/p>
\u3053\u306e\u30cb\u30e5\u30fc\u30b9\u306f\u3001\u5358\u306a\u308b\u30cb\u30c3\u30c1\u306a\u30d8\u30eb\u30b9\u30b1\u30a2\u306e\u6700\u65b0\u60c5\u5831\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u65e5\u672c\u306b\u304a\u3051\u308b\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u898f\u5236\u3001\u60a3\u8005\u30b1\u30a2\u306e\u878d\u5408\u304c\u6f6e\u76ee\u3092\u5909\u3048\u3064\u3064\u3042\u308b\u3053\u3068\u3092\u793a\u3059\u3082\u306e\u3067\u3042\u308a\u3001\u3053\u306e\u5e02\u5834\u3092\u72d9\u3046\u30cf\u30a4\u30c6\u30af\u4f01\u696d\u3001\u533b\u7642\u95a2\u9023\u65b0\u8208\u4f01\u696d\u3001\u56fd\u969b\u7684\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u6559\u8a13\u3092\u4e0e\u3048\u308b\u3082\u306e\u3067\u3059\u3002<\/p>
\u91cd\u8981\u306a\u8981\u56e0\u306f\u3001\u30ea\u30b9\u30af\u306e\u4f4e\u3044\u533b\u7642\u6a5f\u5668\u3068\u3057\u3066\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\uff08SaMD\uff09\u306b\u5bfe\u3059\u308b\u898f\u5236\u7de9\u548c\u306e\u6d41\u308c\u3067\u3059\u3002\u65e5\u672c\u306f\u3001\u30ea\u30b9\u30af\u306e\u4f4e\u3044\u30c7\u30b8\u30bf\u30eb\u6cbb\u7642\u304c\u60a3\u8005\u306b\u5c4a\u304f\u307e\u3067\u306e\u6642\u9593\u3092\u65e9\u3081\u305f\u3044\u3068\u8003\u3048\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u3088\u3046\u306aDTx\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u304c\u5229\u7528\u3057\u3084\u3059\u304f\u306a\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002<\/p>
\u56fd\u5185\u5916\u306e\u30cf\u30a4\u30c6\u30af\u4f01\u696d\u306b\u3068\u3063\u3066\u3001\u3053\u308c\u306f\u969c\u5bb3\u304c\u5c11\u306a\u304f\u306a\u308b\u3053\u3068\u3092\u610f\u5473\u3057\u307e\u3059\u3002\u5e02\u5834\u6295\u5165\u307e\u3067\u306e\u6642\u9593\u304c\u77ed\u7e2e\u3055\u308c\u3001\u81e8\u5e8a\u691c\u8a3c\u3078\u306e\u9053\u7b4b\u304c\u3088\u308a\u660e\u78ba\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u3063\u3066\u6295\u8cc7\u610f\u6b32\u304c\u9ad8\u307e\u308a\u307e\u3059\u3002<\/p>
Japan’s aging population and high healthcare costs create a strong need for digital solutions. DTx applications show promise by focusing on diabetes and smoking cessation. Now, they’re expanding to address key mental health issues such as depression, anxiety, and ADHD. They’re also focusing on cardiovascular and respiratory diseases.<\/p>
\u6cbb\u7642\u6cd5\u304c\u4fdd\u967a\u511f\u9084\u306e\u5bfe\u8c61\u3068\u306a\u308c\u3070\u3001\u304a\u305d\u3089\u304f\u5c0f\u898f\u6a21\u306a\u8a66\u9a13\u7684\u5c0e\u5165\u304b\u3089\u666e\u53ca\u3078\u3068\u9032\u3080\u3067\u3057\u3087\u3046\u3002\u3053\u306e\u5909\u5316\u306f\u3001\u75c5\u9662\u3001\u8a3a\u7642\u6240\u3001\u9060\u9694\u8a3a\u7642\u3067\u8d77\u3053\u308b\u3067\u3057\u3087\u3046\u3002\u305d\u308c\u306f\u533b\u7642\u3092\u4e00\u5909\u3055\u305b\u308b\u3067\u3057\u3087\u3046\u3002<\/p>
Japan’s ecosystem brings together pharmaceutical companies, local digital health firms, universities, and healthcare providers. They all work together to advance DTx development.<\/p>
\u56fd\u5185\u306e\u6210\u9577\u3068\u5916\u56fd\u4f01\u696d\u306e\u95a2\u5fc3\u306f\u3001\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306e\u30c1\u30e3\u30f3\u30b9\u3092\u751f\u307f\u51fa\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u306f\u30e9\u30a4\u30bb\u30f3\u30b9\u4f9b\u4e0e\u3084\u5171\u540c\u958b\u767a\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>
\u4e2d\u5805\u30fb\u4e2d\u5c0f\u306e\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u30fb\u30d7\u30ec\u30fc\u30e4\u30fc\u306f\u3001\u65e5\u672c\u3067\u3088\u308a\u660e\u78ba\u306a\u9053\u7b4b\u3092\u6301\u3066\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u3088\u308a\u5bdb\u5bb9\u306a\u898f\u5236\u74b0\u5883\u3068\u511f\u9084\u3078\u306e\u660e\u78ba\u306a\u9053\u7b4b\u306b\u3088\u308a\u3001\u5730\u57df\u306b\u7279\u5316\u3057\u305fDTx\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u958b\u767a\u306eROI\u306f\u3088\u308a\u73fe\u5b9f\u7684\u306a\u3082\u306e\u306b\u306a\u308a\u307e\u3059\u3002\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u3001\u30e6\u30fc\u30b6\u30fc\u30a8\u30af\u30b9\u30da\u30ea\u30a8\u30f3\u30b9\u3001\u30a8\u30d3\u30c7\u30f3\u30b9\u751f\u6210\u3092\u30ed\u30fc\u30ab\u30e9\u30a4\u30ba\u3059\u308b\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u306f\u5f37\u3044\u3002<\/p>
DTx\u306f\u6cbb\u7642\u305d\u306e\u3082\u306e\u3060\u3051\u3067\u306a\u304f\u3001\u5f37\u529b\u306a\u30d7\u30e9\u30a4\u30d0\u30b7\u30fc\/\u30bb\u30ad\u30e5\u30ea\u30c6\u30a3\u3001\u5b9f\u4e16\u754c\u30c7\u30fc\u30bf\uff08RWD\uff09\u53d6\u5f97\u3001\u5206\u6790\u3001\u30c7\u30d0\u30a4\u30b9\u7d71\u5408\u3001\u76f8\u4e92\u904b\u7528\u6027\u3001\u60a3\u8005\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u30e2\u30b8\u30e5\u30fc\u30eb\u3092\u5099\u3048\u305f\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306a\u3069\u306e\u57fa\u76e4\u30a4\u30f3\u30d5\u30e9\u3082\u9ad8\u3044\u9700\u8981\u304c\u898b\u8fbc\u307e\u308c\u307e\u3059\u3002\u65e5\u672c\u306e\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u3068DTx\u4f01\u696d\u306f\u3001\u30b9\u30b1\u30fc\u30e9\u30d6\u30eb\u306a\u30d0\u30c3\u30af\u30a8\u30f3\u30c9\u3001API\u3001SDK\u3092\u8abf\u9054\u307e\u305f\u306f\u63d0\u643a\u3059\u308b\u3067\u3057\u3087\u3046\u3002<\/p>
\u88fd\u85ac\u4f1a\u793e\u306f\u3001DTx\u3092\u73fe\u5728\u306e\u88fd\u54c1\u306b\u8ffd\u52a0\u307e\u305f\u306f\u62e1\u5f35\u3059\u308b\u3082\u306e\u3068\u8003\u3048\u308b\u3067\u3057\u3087\u3046\u3002\u95a2\u9023\u6027\u3092\u7dad\u6301\u3059\u308b\u305f\u3081\u306b\u3001DTx\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u3092\u8cb7\u53ce\u3057\u305f\u308a\u3001\u63d0\u643a\u3057\u305f\u308a\u3001\u30a4\u30f3\u30ad\u30e5\u30d9\u30fc\u30c8\u3057\u305f\u308a\u3059\u308b\u304b\u3082\u3057\u308c\u307e\u305b\u3093\u3002\u3053\u308c\u306f\u3001\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3068\u533b\u85ac\u54c1\u3084\u533b\u7642\u6a5f\u5668\u306e\u76f8\u4e57\u52b9\u679c\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u3082\u306e\u3067\u3059\u3002\u533b\u7642\u6a5f\u5668\u30e1\u30fc\u30ab\u30fc\u306b\u3068\u3063\u3066\u306f\u3001DTx\u6a5f\u80fd\u3092\u6a5f\u5668\u306b\u7d44\u307f\u8fbc\u3093\u3060\u308a\u3001\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u30a2\u30d7\u30ea\u3068\u9023\u643a\u3055\u305b\u305f\u308a\u3059\u308b\u6a5f\u4f1a\u304c\u751f\u307e\u308c\u307e\u3059\u3002<\/p>
U.S. and global DTx vendors eyeing market entry are well placed, especially those with existing clinical evidence, scalable software platforms, and experience navigating regulatory environments. Japan’s market now represents not just a ‘nice to have,’ but a growth frontier.<\/p>
\u3057\u304b\u3057\u3001\u30ed\u30fc\u30ab\u30e9\u30a4\u30ba\uff08\u8a00\u8a9e\u3001\u81e8\u5e8a\u6163\u884c\u3001\u898f\u5236\u306e\u30cb\u30e5\u30a2\u30f3\u30b9\uff09\u3001\u65e5\u672c\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u3068\u306e\u63d0\u643a\u3084\u30e9\u30a4\u30bb\u30f3\u30b9\u4ea4\u6e09\u3001\u65e5\u672c\u306e\u652f\u6255\u8005\u306b\u5408\u308f\u305b\u305f\u4fa1\u5024\u63d0\u6848\u306a\u3069\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>
DTx\u306e\u666e\u53ca\u306f\u3001\u30b1\u30a2\u63d0\u4f9b\u30e2\u30c7\u30eb\u306e\u9032\u5316\u3092\u610f\u5473\u3057\u307e\u3059\u3002\u75c5\u9662\u3001\u8a3a\u7642\u6240\u3001\u4fdd\u967a\u4f1a\u793e\u306f\u3001\u305d\u308c\u305e\u308c\u306e\u30b7\u30b9\u30c6\u30e0\u306b\u30c7\u30b8\u30bf\u30eb\u6cbb\u7642\u6cd5\u3092\u8ffd\u52a0\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u30d7\u30ed\u30c8\u30b3\u30eb\u3001\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3001\u8a3a\u7642\u5831\u916c\u306e\u51e6\u7406\u65b9\u6cd5\u3092\u66f4\u65b0\u3059\u308b\u3053\u3068\u3092\u610f\u5473\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u7d44\u7e54\u6539\u9769\u3084\u30d7\u30ed\u30bb\u30b9\u306e\u518d\u8a2d\u8a08\u3082\u5fc5\u8981\u3067\u3059\u3002\u6700\u5f8c\u306b\u3001\u65b0\u3057\u3044\u30c7\u30fc\u30bf\u4e3b\u5c0e\u578b\u533b\u7642\u306b\u5099\u3048\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p>
\u511f\u9084\u3068\u4fa1\u683c\u306e\u660e\u78ba\u5316<\/strong>:\u3088\u308a\u591a\u304f\u306eDTx\u88fd\u54c1\u304c\u56fd\u6c11\u5065\u5eb7\u4fdd\u967a\u3067\u30ab\u30d0\u30fc\u3055\u308c\u308b\u3088\u3046\u306b\u306a\u308b\u307e\u3067\u306f\u3001\u305d\u306e\u5c0e\u5165\u306f\u307b\u3068\u3093\u3069\u8a66\u9a13\u7684\u30d7\u30ed\u30b0\u30e9\u30e0\u3068\u533b\u7642\u6a5f\u95a2\u306e\u4e88\u7b97\u306b\u983c\u308b\u3053\u3068\u306b\u306a\u308b\u3067\u3057\u3087\u3046\u3002\u3053\u308c\u3067\u306f\u898f\u6a21\u304c\u9650\u3089\u308c\u307e\u3059\u3002<\/p> \u30a8\u30d3\u30c7\u30f3\u30b9\u3068\u81e8\u5e8a\u7684\u691c\u8a3c<\/strong>:\u65e5\u672c\u306e\u533b\u5e2b\u3068\u652f\u6255\u8005\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u3001\u5b9f\u81e8\u5e8a\u8a66\u9a13\u3001\u533b\u7642\u7d4c\u6e08\u5206\u6790\u306a\u3069\u3001\u5730\u57df\u3054\u3068\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u3092\u5fc5\u8981\u3068\u3057\u307e\u3059\u3002<\/p> \u30c7\u30fc\u30bf\u30d7\u30e9\u30a4\u30d0\u30b7\u30fc\u3068\u898f\u5236<\/strong>:\u60a3\u8005\u306e\u30d7\u30e9\u30a4\u30d0\u30b7\u30fc\u306b\u95a2\u3059\u308b\u898f\u5247\u306f\u53b3\u3057\u3044\u3002\u30b5\u30a4\u30d0\u30fc\u30bb\u30ad\u30e5\u30ea\u30c6\u30a3\u3078\u306e\u671f\u5f85\u306f\u9ad8\u3044\u5730\u57df\u306e\u898f\u5236\u306f\u3001\u6df1\u3044\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u4fe1\u983c\u3092\u8981\u6c42\u3057\u307e\u3059\u3002<\/p> \u30e6\u30fc\u30b6\u30fc\u306e\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3068\u30a2\u30c9\u30d2\u30a2\u30e9\u30f3\u30b9\u304c\u9375<\/strong>:\u7d99\u7d9a\u7684\u306a\u4f7f\u7528\u304cDTx\u306e\u52b9\u679c\u3092\u9ad8\u3081\u307e\u3059\u3002\u79c1\u305f\u3061\u306f\u3001\u6280\u8853\u8a2d\u8a08\u3001\u884c\u52d5\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u3001\u7d99\u7d9a\u7684\u306a\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306b\u91cd\u70b9\u3092\u7f6e\u304f\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u305d\u308c\u304c\u76ee\u6a19\u9054\u6210\u306b\u3064\u306a\u304c\u308a\u307e\u3059\u3002<\/p> \u533b\u7642\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u7d71\u5408<\/strong>:\u96fb\u5b50\u30ab\u30eb\u30c6\u3001\u81e8\u5e8a\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u3001\u4fdd\u967a\u30b7\u30b9\u30c6\u30e0\u3068\u7c21\u5358\u306b\u63a5\u7d9a\u3067\u304d\u307e\u3059\u3002<\/p> Japan’s growing DTx market leads the way for established healthcare systems. It shows how to integrate software-based therapies widely. Japan’s success will lead to lower treatment costs, better chronic disease management, and a better patient experience. This is crucial for an aging society with limited medical resources.<\/p> Japan’s DTx evolution will change how software interacts with medicine. This new space brings together tech companies, health institutions, and patients. They all focus on digital therapeutics. To succeed, businesses in this space must track regulatory changes, form local alliances, generate high-quality evidence, and develop robust engagement and infrastructure capabilities.<\/p>","protected":false},"excerpt":{"rendered":" Japan is quietly becoming one of Asia’s most promising frontiers for digital therapeutics (DTx). Recent data from U.S. trade analysts confirm that Japan’s market for software-driven, evidence-based medical interventions is gaining policy, clinical, and commercial momentum.As of April 2025, only five DTx products have been approved in Japan. However, only two of these are covered by national health insurance.Even with this starting point, projections show strong growth. Sales to healthcare providers are expected to reach about US$ 230 million (¥35 billion) by 2030. This is up from just a few billion yen today.Also Read: Hinge Bio partners with Kyorin to Develop HB2198 in JapanAnother forecast from IQVIA indicates the market […]<\/p>\n","protected":false},"author":7,"featured_media":22138,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,8098],"tags":[7740,8322,1363,392,8163],"ppma_author":[572],"class_list":["post-22137","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-news-articles","tag-digital-therapeutics","tag-dtx-solution","tag-health-tech","tag-healthcare","tag-japan-tech"],"yoast_head":"\n\u5168\u4f53\u50cf\u65e5\u672c\u306b\u3068\u3063\u3066\u3001\u305d\u3057\u3066\u4e16\u754c\u306b\u3068\u3063\u3066<\/strong><\/h2>
\u4e16\u754c\u306e\u30d8\u30eb\u30b9\u30c6\u30c3\u30af\u7523\u696d\u306b\u3068\u3063\u3066\u3001\u65e5\u672c\u304c\u63d0\u4f9b\u3059\u308b\u3082\u306e\uff1a<\/strong><\/h2>
\n